🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 09072V204 (prev. 09072V105 )
- Market Cap
- Micro Cap
- IPO
- 2/4/2014 · $10.00/share
Business: Biocept, Inc. is a molecular oncology diagnostics company specializing in Circulating Tumor Cells and biomarker analysis. The Company employs their unique laboratory technology through an offering of services to medical/surgical oncologists, pathologists, hospitals, cancer centers, universities, and pharmaceutical/clinical researchers.
Notes: May 17, 2023 -- Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, announces that as a result of its 1-for-30 reverse stock split that became effective at 4:05 p.m. Eastern Time on May 16, 2023, its common stock will begin trading on a split-adjusted basis with the open of the market today, May 17, 2023. Biocept’s common stock will continue to trade under the existing trading symbol “BIOC.” <p> September 29, 2016 -- Biocept, Inc. (BIOC) will effect a one-for-three (1-3) reverse split of its common stock. The CUSIP number will change to 09072V204.
Company Contact
- CEO
- Antonino Morales
- CFO
- Antonino Morales
- Headquarters
- 9955 Mesa Rim Road, San Diego, CA 92121
- Phone
- 858-320-8200 · Toll-Free 888-332-7729
- Fax
- 877-300-1761
- Investor Relations
- Jody Cain, LHA IR · 310-691-7100 · Jcain@lhai.com